Terns Pharmaceuticals (TERN) had the highest return between August 1, 2022 and October 12, 2022 by a small-cap US stock, returning 201.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Terns Pharmaceuticals (TERN) | 8/1/2022 - 10/12/2022 | 201.37% |
Astria Therapeutics (ATXS) | 8/1/2022 - 10/12/2022 | 131.13% |
89bio (ETNB) | 8/1/2022 - 10/12/2022 | 122.88% |
Enliven Therapeutics (ELVN) | 8/1/2022 - 10/12/2022 | 114.78% |
Vigil Neuroscience (VIGL) | 8/1/2022 - 10/12/2022 | 105.01% |
Ardelyx (ARDX) | 8/1/2022 - 10/12/2022 | 97.1% |
SS Innovations International Inc Common Stock (SSII) | 8/1/2022 - 10/12/2022 | 96.77% |
EVI Industries (EVI) | 8/1/2022 - 10/12/2022 | 92% |
Biohaven Pharmaceutical (BHVN) | 8/1/2022 - 10/12/2022 | 84.83% |
Harrow Health (HROW) | 8/1/2022 - 10/12/2022 | 81.71% |
Wave Life Sciences (WVE) | 8/1/2022 - 10/12/2022 | 81.35% |
Prothena (PRTA) | 8/1/2022 - 10/12/2022 | 71.66% |
Larimar Therapeutics (LRMR) | 8/1/2022 - 10/12/2022 | 65.78% |
Sigma Lithium Resources (SGML) | 8/1/2022 - 10/12/2022 | 65.53% |
Applied Opt (AAOI) | 8/1/2022 - 10/12/2022 | 54.71% |
Fubotv (FUBO) | 8/1/2022 - 10/12/2022 | 54.62% |
Viridian Therapeutics (VRDN) | 8/1/2022 - 10/12/2022 | 52.53% |
Cooper Stnd (CPS) | 8/1/2022 - 10/12/2022 | 48.51% |
Pacific Biosciences of California (PACB) | 8/1/2022 - 10/12/2022 | 47.7% |
UroGen Pharma (URGN) | 8/1/2022 - 10/12/2022 | 46.29% |
Cricut (CRCT) | 8/1/2022 - 10/12/2022 | 45.47% |
Limbach (LMB) | 8/1/2022 - 10/12/2022 | 44.49% |
Capricor Therapeutics (CAPR) | 8/1/2022 - 10/12/2022 | 43.64% |
Abeona Therapeutics (ABEO) | 8/1/2022 - 10/12/2022 | 43.59% |
Keros Therapeutics (KROS) | 8/1/2022 - 10/12/2022 | 40.85% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
